Workflow
澳洋健康(002172.SZ):2025年三季报净利润为4011.37万元

Core Insights - The company reported a total revenue of 1.36 billion yuan for Q3 2025, a decrease of 141 million yuan compared to the same period last year, representing a year-on-year decline of 9.39% [1] - The net profit attributable to shareholders was 40.11 million yuan, ranking 26th among disclosed peers [1] - The company experienced a negative cash flow from operating activities amounting to -28.66 million yuan, ranking 45th among disclosed peers [1] Financial Metrics - The latest debt-to-asset ratio is 91.97%, ranking 51st among disclosed peers [3] - The gross profit margin is 14.27%, ranking 48th, with a decrease of 0.57 percentage points from the previous quarter [3] - The return on equity (ROE) is 22.97%, down 6.21 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.05 yuan, ranking 33rd among disclosed peers [3] - The total asset turnover ratio is 0.68 times, a decrease of 0.04 times year-on-year, representing a decline of 4.98% [3] - The inventory turnover ratio is 8.24 times [3] Shareholder Structure - The number of shareholders is 58,300, with the top ten shareholders holding a total of 276 million shares, accounting for 36.02% of the total share capital [3] - The largest shareholder is Aoyang Group Co., Ltd., holding 30.7% of the shares [3] - Other notable shareholders include Shen Qing (2.24%), Tui Jian (1.31%), and Li Anming (0.37%) [3]